🔎 Trials Near Me

Utama › Mieloma Pelbagai Berterusan › New York

Kajian klinikal Mieloma Pelbagai Berterusan di New York

8 kajian untuk Mieloma Pelbagai Berterusan sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07393282

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
  • Mount Sinai Chelsea, New York
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT03937635

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

  • NYU Langone Health Perlmutter Cancer Center, New York
  • Stony Brook University Hospital, Stony Brook
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06140524

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT05640843

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

  • Roswell Park Cancer Institute, Buffalo
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Dis 2025 · NCT05312255

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Nov 2025 · NCT06055894

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaKajian pemerhatian
Umur 40 ke atas · Semua jantina · Dikemas kini 6 Ogo 2025 · NCT06365060

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

  • University of Rochester, Rochester
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Feb 2025 · NCT05597345

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.